Cargando…
Novel Approaches Used to Examine and Control Neurogenesis in Parkinson′s Disease
Neurogenesis is a key mechanism of brain development and plasticity, which is impaired in chronic neurodegeneration, including Parkinson’s disease. The accumulation of aberrant α-synuclein is one of the features of PD. Being secreted, this protein produces a prominent neurotoxic effect, alters synap...
Autores principales: | Salmina, Alla B., Kapkaeva, Marina R., Vetchinova, Anna S., Illarioshkin, Sergey N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431772/ https://www.ncbi.nlm.nih.gov/pubmed/34502516 http://dx.doi.org/10.3390/ijms22179608 |
Ejemplares similares
-
Mitochondrial Dysfunction in Dopaminergic Neurons Derived from Patients with LRRK2- and SNCA-Associated Genetic Forms of Parkinson’s Disease
por: Vetchinova, Anna S., et al.
Publicado: (2023) -
Influence of N-Arachidonoyl Dopamine and N-Docosahexaenoyl Dopamine on the Expression of Neurotrophic Factors in Neuronal Differentiated Cultures of Human Induced Pluripotent Stem Cells under Conditions of Oxidative Stress
por: Novosadova, Ekaterina, et al.
Publicado: (2022) -
Early Life Stress and Metabolic Plasticity of Brain Cells: Impact on Neurogenesis and Angiogenesis
por: Salmina, Alla B., et al.
Publicado: (2021) -
SNCA Gene Methylation in Parkinson’s Disease and Multiple System Atrophy
por: Fedotova, Ekaterina Yu., et al.
Publicado: (2023) -
Potential Biomarkers of the Earliest Clinical Stages of Parkinson's Disease
por: Alieva, Anelya Kh., et al.
Publicado: (2015)